SMS Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

301.98

223.82

182.17

337.70

243.02

Operating profit

54.48

13.19

22.99

91.49

45.53

Interest

11.89

10.09

9.09

9.78

5.67

Gross profit

43.91

4.51

16.46

84.35

41.17

EPS (Rs)

2.52

-1.07

2.31

5.73

2.41

Other income

1.32

1.41

2.56

2.64

1.31

Stock adjustment

-23.00

3.09

-46.39

-66.11

10.96

Raw material

194.84

148.42

140.99

246.81

144.14

Power and fuel

-

-

-

-

-

Employee expenses

27.20

25.69

27.00

24.02

18.03

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

48.47

33.43

37.58

41.50

24.36

Provisions made

-

-

-

-

-

Depreciation

15.59

16.03

16.07

16.08

11.11

Taxation

6.99

-2.49

-19.18

19.80

9.63

Net profit / loss

21.33

-9.02

19.57

48.47

20.43

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

8.47

8.47

8.47

8.47

8.47

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

18.04

5.89

12.62

27.09

18.73

GPM (%)

14.48

2.00

8.91

24.78

16.85

NPM (%)

7.03

-4.00

10.59

14.24

8.36